Opalińska, M., Sowa-Staszczak, A., Grochowska, A., Olearska, H., & Hubalewska-Dydejczyk, A. (2021). Value of Peptide Receptor Radionuclide Therapy as Neoadjuvant Treatment in the Management of Primary Inoperable Neuroendocrine Tumors. Frontiers Media S.A.
Style de citation Chicago (17e éd.)Opalińska, Marta, Anna Sowa-Staszczak, Anna Grochowska, Helena Olearska, et Alicja Hubalewska-Dydejczyk. Value of Peptide Receptor Radionuclide Therapy as Neoadjuvant Treatment in the Management of Primary Inoperable Neuroendocrine Tumors. Frontiers Media S.A, 2021.
Style de citation MLA (8e éd.)Opalińska, Marta, et al. Value of Peptide Receptor Radionuclide Therapy as Neoadjuvant Treatment in the Management of Primary Inoperable Neuroendocrine Tumors. Frontiers Media S.A, 2021.
Attention : ces citations peuvent ne pas être correctes à 100%.